XTRA:FREHealthcare
Fresenius (XTRA:FRE) Stock Eyes Margin Led Rerating After EPS Lift
The market had already pushed Fresenius SE KGaA up over the past quarter, with the stock closing at €46.65 on 5 August after a solid 90 day run. Today investors had to decide whether that optimism fits the new reality. The headline is clear. Fresenius delivered a health care earnings story built on profit quality, not hype, with core earnings per share for Q2 of €0.68 and group EBIT margin at 12.3%.
The emotional pivot is this margin story. Traders focused on short term headlines risk missing...